The $15 billion acquisition of a California maker of vascular devices is Boston Scientific's biggest since 2006.

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as ...

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept a ...